mitoxantrone has been researched along with Cognition Disorders in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinner, M | 1 |
| Hoepner, R | 1 |
| Klotz, P | 1 |
| Prehn, C | 1 |
| Faissner, S | 1 |
| Salmen, A | 1 |
| Linker, RA | 1 |
| Gold, R | 1 |
| Chan, A | 1 |
| Zéphir, H | 1 |
| de Sèze, J | 1 |
| Dujardin, K | 1 |
| Dubois, G | 1 |
| Cabaret, M | 1 |
| Bouillaguet, S | 1 |
| Ferriby, D | 1 |
| Stojkovic, T | 1 |
| Vermersch, P | 1 |
| Bagert, B | 1 |
| Camplair, P | 1 |
| Bourdette, D | 1 |
1 review available for mitoxantrone and Cognition Disorders
| Article | Year |
|---|---|
Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.
Topics: Adjuvants, Immunologic; Brain; Cognition Disorders; Depressive Disorder; Diagnosis, Differential; Di | 2002 |
1 trial available for mitoxantrone and Cognition Disorders
| Article | Year |
|---|---|
[Cognitive impact of mitoxantrone and methylprednisolone in multiple sclerosis: an open label study].
Topics: Adult; Analgesics; Anti-Inflammatory Agents; Cognition Disorders; Depression; Disease Progression; F | 2008 |
1 other study available for mitoxantrone and Cognition Disorders
| Article | Year |
|---|---|
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
Topics: Adolescent; Adult; Cognition Disorders; Disability Evaluation; Female; Humans; Immunosuppressive Age | 2016 |